関連する実験動画

Updated: Dec 9, 2025

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.0K

一回投与の鼻内チャドワクチンにより,SARS-CoV-2に対する上下呼吸道が保護されます

Ahmed O Hassan1, Natasha M Kafai2, Igor P Dmitriev3

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell
|September 15, 2020
PubMed
まとめ

チンパンジーアデノウイルスベクトルワクチン (ChAd-SARS-CoV-2-S) は有望である. この重症急性呼吸器症候群コロナウイルス2 (SARS-CoV-2) ワクチン候補の鼻内投与は,感染をほぼ排除し,感染を予防する可能性があります.

キーワード:
コロナウイルスIgA ウイルスSARS-CoV-2についてT細胞抗体について鼻内投与粘膜免疫病原性保護するワクチン

さらに関連する動画

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K

関連する概念動画

Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
758